Adverse event reports in patients taking psychiatric medication during pregnancy from spontaneous reports in Japan and the United States: an approach using latent class analysis

被引:0
作者
Tatsuhiko Anzai
Kunihiko Takahashi
Michiko Watanabe
Mayumi Mochizuki
Atsuko Murashima
机构
[1] Keio University Graduate School of Health Management,Department of Biostatistics
[2] Statistics Analysis Department 1,Japan Drug Information Institute in Pregnancy (J
[3] Nagoya University Graduate School of Medicine,TIS)
[4] Keio University Faculty of Pharmacy,undefined
[5] National Center for Child Health and Development,undefined
来源
BMC Psychiatry | / 20卷
关键词
pregnancy; adverse events; psychiatric medication; spontaneous reports; latent class analysis; polypharmacy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 136 条
  • [1] Rahman A(2004)Impact of maternal depression on infant nutritional status and illness: A cohort study Arch Gen Psychiatry. 61 946-952
  • [2] Iqbal Z(2009)Psychiatric disorders in pregnancy J Perinat Neonatal Nurs. 23 124-130
  • [3] Bunn J(2008)Psychiatric disorders in pregnant and postpartum women in the United States Arch Gen Psychiatry. 65 805-815
  • [4] Lovel H(2013)Examination of pregnancies in patients with psychiatric disorders: the relationships between fetal or neonatal complications and maternal psychotropic drug use Japanese Soc Gen Hosp Psychiatry. 25 287-294
  • [5] Harrington R(2013)Prevalence of antidepressant use during pregnancy in Denmark, a nation-wide cohort study PLoS One. 8 1-8
  • [6] Van Mullem C(2007)Increasing use of antidepressants in pregnancy Am J Obstet Gynecol 196 544.e1-544.e5
  • [7] Tillett J(2016)Antidepressant Prescription Claims Among Reproductive-Aged Women With Private Employer-Sponsored Insurance — United States 2008–2013 MMWR Morb Mortal Wkly Rep. 65 41-46
  • [8] Vesga-López O(2010)National Trends in Psychotropic Medication Polypharmacy in Office-Based Psychiatry Arch Gen Psychiatry. 67 26-1190
  • [9] Blanco C(2017)The importance of pharmacoepidemiology in pregnancy-implications for safety Expert Opin Drug Saf. 16 1181-23
  • [10] Keyes K(2012)Spontaneous reporting in pharmacovigilance: strengths, weaknesses and recent methods of analysis J Clin Prev Cardiol. 1 20-33